SEC Form 4 · accession 0001179110-17-006131
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard John Roberts
Director
Period of report
Apr 13, 2017
Accepted (ET)
Apr 20, 2017 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 13, 2017 | M | 30,984 | $0.2904 | A | 216,887 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock option (right to buy)F1 | $0.2904 | Apr 13, 2017 | M | 30,984 | D | — | Nov 24, 2018 | Common Stock | 30,984 | 0 | D |
Explanation of responses
- F1The option became exercisable in four equal annual installments beginning on November 24, 2009, which was the first anniversary of the date on which the option was granted.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney